You are here:Home
»
Molecular Biology
»
MB-Cancer Markers
»
Carcinoembryonic Antigen, Recombinant, Human, 95+% (CEA, CD66e)
Carcinoembryonic Antigen, Recombinant, Human, 95+% (CEA, CD66e)
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| Carcinoembryonic antigen (CEA) is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Carcinoembryonic Antigen, Recombinant, is produced from human colon carcinoma cell lines. | | | Catalog # | C1300-08B | | Applications | Suitable for use in ELISA. Other applications not tested. | | Recommended Dilution | Optimal dilutions to be determined by the researcher. | | Storage and Stability | May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | | Source | Human, recombinant expressed by colon carcinoma cell lines | | Purity | 95% by SDS-PAGE | | Concentration | ~2mg/ml (Elecsys) | | Form | Supplied as a 0.2um sterile-filtered liquid in PBS, pH 7.4, 0.1% sodium azide. No stabilizing proteins added. | | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
External Links
|
